Dentsply Sirona Q2 2026 Results: Sales Dip, Profit Returns

Dentsply Sirona reported second quarter 2026 results on August 6. Net sales fell to $898 million from $936 million a year earlier. Net income swung to a $37 million gain. The two moves have different causes.

TL;DR

• Dentsply Sirona posted $898 million in Q2 2026 net sales, down 4.1% year over year.

• Net income hit $37 million, mainly because Q2 2025 carried a $235 million impairment charge that did not repeat.

• Orthodontic and Implant Solutions fell 13.2%, the steepest segment decline and the main drag on total sales.

• The company held its full-year outlook of $3.5 billion to $3.6 billion in sales.

Revenue and Profit Snapshot

Q2 2026 net sales landed at $898 million, according to the company's earnings release. That figure marks a 4.1% drop from $936 million in Q2 2025.

The profit swing looks larger than the sales decline. One factor explains most of it. Q2 2025 included a $235 million non-cash goodwill and intangible asset impairment. Q2 2026 carried no such charge. That absence is the main reason net income flipped from a loss to a gain.

Gross margin also improved, reaching 54.9% versus 52.4% a year earlier. Cost of products sold fell to $405 million from $446 million, even as sales declined. That gap between shrinking revenue and shrinking cost lifted the margin, not stronger unit sales.

Net income attributable to Dentsply Sirona reached $37 million. Q2 2025 posted a $45 million net loss instead. Adjusted EBITDA came in at $190 million, down slightly from $197 million. Adjusted EPS held steady at $0.52. That figure already excludes one-time items like last year's impairment.

Segment Performance Breakdown

Results varied sharply across the company's four reporting segments. Three of four posted lower sales.

Orthodontic and Implant Solutions posted the steepest decline, falling 13.2% to $197 million. That single segment accounted for most of the company's total dollar decline. Essential Dental Solutions dropped 2.7% to $376 million. Connected Technology Solutions slipped 1.5% to $239 million, a smaller drop than the other two.

Wellspect Healthcare was the only segment to grow, rising 7.1% to $86 million. Its size is too small to offset losses elsewhere.

Connected Technology Solutions includes the company's DS Core cloud platform for digital scans and lab orders. Its smaller decline suggests digital workflow tools held up better than implant and aligner sales.

Cash Flow and Capital Moves

Operating cash flow rose to $99 million in Q2 2026, up from $48 million. About $44 million came from tariff refunds, a one-time item separate from the impairment swing above.

Free cash flow reached $55 million, compared to $16 million in Q2 2025. The company repurchased 1.3 million shares for about $12 million during the quarter. Cash and cash equivalents stood at $239 million as of June 30.

Dentsply Sirona also announced an expanded partnership with Medline Sinclair. That deal broadens distributor access to Connected Technology Solutions across Canada, this quarter's steadiest segment.

Outlook and Leadership Commentary

The company maintained its full-year 2026 outlook, according to the earnings release. Net sales guidance stays between $3.5 billion and $3.6 billion. Adjusted EPS is projected between $1.40 and $1.50.

President and CEO Dan Scavilla said the quarter reflected continued execution of the Return-to-Growth plan. The plan targets stronger distributor relationships and realigned sales teams. Reinvestment across the business is also part of the strategy, according to the earnings release.

The tariff refund benefit is excluded from the 2026 adjusted EPS outlook. That keeps guidance tied to core operating performance, not a one-time cash inflow.

Bottom Line

Dentsply Sirona's second quarter tells two separate stories. Sales slipped mainly because Orthodontic and Implant Solutions lost ground, while the rest of the business held closer to steady. Profit improved largely due to the absence of last year's impairment charge, and cash flow got an added boost from a one-time tariff refund. Guidance held steady through it all.